BIOA BIOAGE LABS
Health Care · Russell 2000
Next earnings: not announced yet
What 12 analyst firms say about BIOAGE LABS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
10 rated views · 12 analyst/firm records · 12 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8042
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8030
Recent analyst activity · last 90 days
Our tracked history has 7 reports on BIOA from 4 analyst firms in the last 90 days (12 firms in the past year).
Comparing each firm's latest target with its previous one: 3 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Roth Capital lowered its target from $36.00 (set 27 May 2026) to $25.00 on 8 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Thomas Shrader | Buy | 8 Sep 2026 | 40.00 USD |
| Citigroup | Samantha Semenkow | Buy | 6 Aug 2026 | 21.00 USD |
| Jefferies | Roger Song | Buy | 3 Aug 2026 | 21.00 USD |
| Morgan Stanley | Jeffrey Hung | — | 4 Feb 2026 | 23.00 USD |
| Needham | Joseph Stringer | Buy | 31 Jul 2026 | 35.00 USD |
| Oppenheimer | Jay Olson | Buy | 25 Feb 2026 | 60.00 USD |
| Piper Sandler | Yasmeen Rahimi | Buy | 8 May 2026 | 73.00 USD |
| Roth Capital | Adam Walsh | Buy | 9 Sep 2026 | 25.00 USD |
| UBS | Alice Nettleton | Hold | 11 Oct 2026 | 8.00 USD |
| Weiss Ratings | Unnamed analyst | — | 26 Oct 2026 | — |
| William Blair | Andy T Hsieh | Hold | 31 Jul 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.